Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
IMAC Holdings, Inc. (BACK)
USD0.02
0.00 (-0.48%)
US OTC Healthcare Medical - Care Facilities
Address
1605 Westgate Circle 37027
Brentwood, TN, US
Brentwood, TN, US
CEO
Faith Zaslavsky
Website
imacholdings.com
IPO
2019-02-13
CIK 1729944 ISIN US44967K3023
Also trades on
NASDAQ Capital Market · IMAC (USD)
NASDAQ Capital Market · IMACW (USD)
Other OTC · BACK (USD)
Description
IMAC Holdings, Inc. operates a network of advanced medical and regenerative care facilities across the United States. Through its outpatient clinics, the company delivers a range of regenerative, orthopedic, and minimally invasive treatments. These services target individuals suffering from various ailments, including sports-related injuries, damage to ligaments and tendons, other soft tissue issues, and chronic pain in the back, knees, and other joints. Additionally, IMAC offers physical therapy, spinal decompression, and chiropractic manipulation. Currently, IMAC Holdings oversees 15 outpatient medical centers situated in six states: Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. Established in 2000, IMAC Holdings, Inc. maintains its corporate headquarters in Brentwood, Tennessee.
Market Cap & Enterprise Value
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.02
0.00 (-0.48%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
5.6K
Beta
1.71
Float Shares
3.72M
Free Float %
98.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -10.00% | +12.50% | +4.65% | -25.00% | -43.04% | -67.63% | +21.62% | -98.88% | -99.92% | -99.96% | -99.96% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Hold
Price Targets & DCF
Current price
0.02
DCF (Levered)
0.26
+1,172.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-468.27
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-98.6% Q3'25: -62.3% (vs Q3'24)
-
EPS growth Medical - Care Facilities: +19.2%-5.4% Q3'25: +26.3% (vs Q3'24)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-1,512.1% Q3'25: -6,705.2% (vs Q3'24)
-
EBIT margin Medical - Care Facilities: +11.3%-7,799.9% Q3'25: -12,258.2% (vs Q3'24)
-
ROIC Medical - Care Facilities: +6.8%— Q3'25: +113.2% (vs Q3'24)
-
Share dilution Medical - Care Facilities: +0.0%+41.2% Q3'25: +167.5% (vs Q3'24)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.00× Q3'25: -0.38× (vs Q3'24)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
15.13M
est: 15.86M (-4.6%)
|
12.84M
est: 14.42M (-11.0%)
|
14.39M
est: 13.80M (+4.2%)
|
16.19M
est: 17.00M (-4.8%)
|
5.20M
est: 6.00M (-13.4%)
|
72.1K
est: 4.00M (-98.2%)
|
29.37M
est.
|
32.31M
32.31M – 32.31M
+10.0% YoY
|
| EBITDA |
-4.50M
est: -11.00M (+59.1%)
|
-3.26M
est: -10.00M (+67.4%)
|
-8.39M
est: -9.57M (+12.3%)
|
-10.20M
est: -11.79M (+13.5%)
|
-5.95M
est: -4.16M (-42.9%)
|
-5.48M
est: -2.77M (-97.6%)
|
-20.36M
est.
|
-22.40M
-22.40M – -22.40M
-10.0% YoY
|
| EBIT |
-6.05M
est: -12.11M (+50.0%)
|
-4.98M
est: -11.01M (+54.8%)
|
-10.04M
est: -10.53M (+4.7%)
|
-11.83M
est: -12.98M (+8.8%)
|
-6.35M
est: -4.58M (-38.7%)
|
-5.62M
est: -3.05M (-84.1%)
|
-22.42M
est.
|
-24.66M
-24.66M – -24.66M
-10.0% YoY
|
| Net Income |
-6.95M
est: -25.90M (+73.2%)
|
-5.57M
est: -21.35M (+73.9%)
|
-10.54M
est: -23.78M (+55.7%)
|
-18.31M
est: -16.01M (-14.4%)
|
-9.42M
est: -12.53M (+24.8%)
|
-9.05M
est: -3.97M (-127.8%)
|
-5.46M
est.
|
-15.54M
-15.54M – -15.54M
-184.5% YoY
|
| SGA |
17.22M
est: 138.27M (-87.5%)
|
16.38M
est: 125.74M (-87.0%)
|
21.06M
est: 120.29M (-82.5%)
|
22.90M
est: 148.18M (-84.5%)
|
1.47M
est: 52.30M (-97.2%)
|
2.82M
est: 34.87M (-91.9%)
|
255.99M
est.
|
281.59M
281.59M – 281.59M
+10.0% YoY
|
| EPS |
-28.55
est: -16.50 (-73.0%)
|
-15.11
est: -13.60 (-11.1%)
|
-14.02
est: -15.15 (+7.5%)
|
-19.43
est: -10.20 (-90.5%)
|
-5.82
est: -7.98 (+27.1%)
|
-7.76
est: -2.53 (-206.7%)
|
-3.48
est.
|
-9.90
-9.90 – -9.90
-184.5% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B- | 2/5 | 5/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-2.75M
OE per share TTM
-0.73
Owner's Yield
-1,616.67%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
43.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
1
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Peter S. Lynch | 1.39M | 4.24% | 196.5K | 1.19M | 196.5K | 1.19M | IN | United States of America | 2023-01-23 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
5
Sells
0
Shares acquired
16.7K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+16,665
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | Schwartz Matthew Wilson | Director | A-Award | A | Common Stock, no par value | 3,333 | 0.00 | — | 3,333 | D | ↗ |
| 2024-12-31 | Pruitt Michael D | Director | A-Award | A | Common Stock, no par value | 3,333 | 0.00 | — | 12,141 | D | ↗ |
| 2024-12-31 | Evans Maurice E. | Director | A-Award | A | Common Stock, no par value | 3,333 | 0.00 | — | 13,747 | D | ↗ |
| 2024-12-31 | Busch Jeffrey | Director | A-Award | A | Common Stock, no par value | 3,333 | 0.00 | — | 3,333 | D | ↗ |
| 2024-12-31 | Beitsch Peter | Director | A-Award | A | Common Stock, no par value | 3,333 | 0.00 | — | 3,333 | D | ↗ |
| 2024-09-19 | Busch Jeffrey | Director | — | — | Series C-1 Convertible Preferred Stock | 108,420 | 2.56 | 277.7K | 0 | D | ↗ |
| 2024-09-09 | Sucoff Cary | Director | A-Award | A | Restricted Stock Units | 3,333 | 0.00 | — | 3,333 | — | ↗ |
| 2024-06-26 | Schwartz Matthew Wilson | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-26 | Beitsch Peter | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-05-23 | Zaslavsky Faith | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-04-05 | Ruiz Jorge | 10% Owner | P-Purchase | A | Common stock | 1 | 2.69 | 2.69 | 141,230 | D | ↗ |
| 2024-03-27 | Ruiz Jorge | 10% Owner | S-Sale | D | Common stock | 5,000 | 3.00 | 15.0K | 141,229 | D | ↗ |
| 2024-03-25 | Ruiz Jorge | 10% Owner | S-Sale | D | Common stock | 356 | 2.44 | 868.64 | 146,229 | D | ↗ |
| 2024-03-22 | Ruiz Jorge | 10% Owner | S-Sale | D | Common stock | 16,487 | 2.42 | 40.0K | 148,385 | D | ↗ |
| 2023-12-31 | Ruiz Jorge | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-20 | Sucoff Cary | Director | M-Exempt | A | Common Stock | 3,333 | 0.00 | — | 10,000 | — | ↗ |
| 2023-12-20 | Pruitt Michael D | Director | M-Exempt | A | Common Stock | 3,333 | 0.00 | — | 8,808 | — | ↗ |
| 2023-12-20 | Evans Maurice E. | Director | M-Exempt | A | Common Stock | 3,333 | 0.00 | — | 10,414 | — | ↗ |
| 2022-10-15 | Sucoff Cary | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 200,000 | — | ↗ |
| 2022-10-15 | Pruitt Michael D | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 201,250 | — | ↗ |
| 2022-10-15 | Evans Maurice E. | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 212,420 | — | ↗ |
| 2022-05-21 | Gardzina Sheri | Officer | M-Exempt | D | Time-Based Restricted Stock Unit | 9,375 | 0.00 | — | 9,375 | — | ↗ |
| 2022-05-21 | Ervin Jeffrey S | Director / Officer | M-Exempt | A | Common Stock | 37,500 | 0.00 | — | 371,400 | — | ↗ |
| 2022-02-21 | Lerner Benjamin S | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-01-01 | Sucoff Cary | Director | M-Exempt | A | Common Stock | 50,000 | 0.00 | — | 100,000 | — | ↗ |
| 2022-01-01 | Pruitt Michael D | Director | M-Exempt | A | Common Stock | 50,000 | 0.00 | — | 101,250 | — | ↗ |
| 2022-01-01 | Evans Maurice E. | Director | M-Exempt | A | Common Stock | 50,000 | 0.00 | — | 112,420 | — | ↗ |
| 2021-11-01 | Sucoff Cary | Director | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 50,000 | — | ↗ |
| 2021-11-01 | Pruitt Michael D | Director | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 51,250 | — | ↗ |
| 2021-11-01 | Evans Maurice E. | Director | M-Exempt | D | Restricted Stock Unit | 12,500 | 0.00 | — | 50,000 | — | ↗ |
| 2021-08-01 | Sucoff Cary | Director | M-Exempt | D | Restricted Stock Unit | 12,500 | 0.00 | — | 62,500 | — | ↗ |
| 2021-08-01 | Pruitt Michael D | Director | M-Exempt | D | Restricted Stock Unit | 12,500 | 0.00 | — | 62,500 | — | ↗ |
| 2021-08-01 | Evans Maurice E. | Director | M-Exempt | D | Restricted Stock Unit | 12,500 | 0.00 | — | 62,500 | — | ↗ |
| 2021-05-21 | Gardzina Sheri | Officer | M-Exempt | A | Common Stock | 9,375 | 0.00 | — | 18,850 | — | ↗ |
| 2021-05-21 | Ervin Jeffrey S | Director / Officer | M-Exempt | D | Time-Based Restricted Stock Units | 37,500 | 0.00 | — | 75,000 | — | ↗ |
| 2021-04-30 | Sucoff Cary | Director | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 25,000 | — | ↗ |
| 2021-04-30 | Pruitt Michael D | Director | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 26,250 | — | ↗ |
| 2021-04-30 | Evans Maurice E. | Director | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 37,420 | — | ↗ |
| 2021-04-07 | Wallis Matthew C | Director / Officer | S-Sale | D | Common Stock | 400,000 | 1.60 | 640.0K | 1,751,694 | — | ↗ |
| 2021-03-25 | Pruitt Michael D | Director | P-Purchase | A | Common Stock | 750 | 1.64 | 1.2K | 13,750 | — | ↗ |
| 2021-01-31 | Sucoff Cary | Director | M-Exempt | D | Restricted Stock Unit | 12,500 | 0.00 | — | 87,500 | — | ↗ |
| 2021-01-31 | Pruitt Michael D | Director | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 13,000 | — | ↗ |
| 2021-01-31 | Evans Maurice E. | Director | M-Exempt | A | Common Stock | 12,500 | 0.00 | — | 24,920 | — | ↗ |
| 2020-10-31 | Sucoff Cary | Director | A-Award | A | Restricted Stock Unit | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2020-10-31 | Pruitt Michael D | Director | A-Award | A | Restricted Stock Unit | 100,000 | 0.00 | — | 100,000 | — | ↗ |
| 2020-10-31 | Evans Maurice E. | Director | — | D | Common Stock | 0 | 0.00 | — | 12,420 | — | ↗ |
| 2020-09-10 | Ervin Jeffrey S | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 0.79 | 3.1K | 296,400 | — | ↗ |
| 2020-05-21 | HAYDEN GERARD M JR | Director | A-Award | A | Time-Based Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2020-05-21 | HAMPTON GEORGE P | Director | M-Exempt | D | Time-Based Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2020-05-21 | Gardzina Sheri | Officer | M-Exempt | D | Time-Based Restricted Stock Units | 9,375 | 0.00 | — | 28,125 | — | ↗ |
| 2020-05-21 | Ervin Jeffrey S | Director / Officer | M-Exempt | D | Time-Based Restricted Stock Units | 37,500 | 0.00 | — | 112,500 | — | ↗ |
| 2020-05-21 | Ellwanger David | Director | M-Exempt | D | Time-Based Restricted Stock Units | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2020-04-03 | Ervin Jeffrey S | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 1.45 | 1.5K | 263,900 | — | ↗ |
| 2020-02-10 | HAYDEN GERARD M JR | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-01-24 | HAMPTON GEORGE P | Director | A-Award | A | Non-Qualified Stock Options | 10,000 | 1.42 | 14.2K | 10,000 | — | ↗ |
| 2020-01-24 | Ellwanger David | Director | A-Award | A | Non-Qualified Stock Options | 10,000 | 1.42 | 14.2K | 10,000 | — | ↗ |
| 2019-11-19 | Ervin Jeffrey S | Director / Officer | P-Purchase | A | Common Stock | 100 | 2.26 | 226.00 | 262,900 | — | ↗ |
| 2019-11-18 | Ervin Jeffrey S | Director / Officer | P-Purchase | A | Common Stock | 100 | 2.10 | 210.00 | 262,300 | — | ↗ |
| 2019-05-21 | Weiland Dean | Director | M-Exempt | A | Common Stock, par value $0.001 | 10,000 | 0.00 | — | 19,756 | — | ↗ |
| 2019-05-21 | HAMPTON GEORGE P | Director | M-Exempt | A | Common Stock, par value $0.001 | 10,000 | 0.00 | — | 12,146 | — | ↗ |
| 2019-05-21 | Gardzina Sheri | Officer | A-Award | A | Non-Qualified Stock Options | 37,500 | 4.04 | 151.5K | 37,500 | — | ↗ |
| 2019-05-21 | Ervin Jeffrey S | Director / Officer | A-Award | A | Non-Qualified Stock Options | 150,000 | 4.04 | 606.0K | 150,000 | — | ↗ |
| 2019-05-21 | Ellwanger David | Director | M-Exempt | A | Common Stock, par value $0.001 | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2019-04-30 | Gardzina Sheri | Officer | — | I | Common Stock | 0 | 0.00 | — | 100 | — | ↗ |
| 2019-02-22 | Wallis Matthew C | Director / Officer / 10% Owner | J-Other | A | Common Stock | 382,287 | 5.00 | 1.91M | 2,151,694 | — | ↗ |
| 2019-02-22 | Ervin Jeffrey S | Director / Officer | C-Conversion | A | Common Stock | 12,835 | 5.00 | 64.2K | 261,700 | — | ↗ |
| 2019-02-15 | Weiland Dean | Director | P-Purchase | A | Common Stock | 9,756 | 5.13 | 50.0K | 9,756 | — | ↗ |
| 2019-02-15 | HAMPTON GEORGE P | Director | P-Purchase | A | Common Stock | 2,146 | 5.13 | 11.0K | 2,146 | — | ↗ |
| 2019-02-15 | Gardzina Sheri | Officer | — | D | Warrants (right to buy) | 200 | 5.00 | 1.0K | 0 | — | ↗ |
| 2019-02-12 | Weiland Dean | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-02-12 | Wallis Matthew C | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,676,445 | — | ↗ |
| 2019-02-12 | HAMPTON GEORGE P | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-02-12 | Ervin Jeffrey S | Officer | — | D | Common Stock | 0 | 0.00 | — | 248,865 | — | ↗ |
| 2019-02-12 | Ellwanger David | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-02-12 | Bond Dwight Anthony | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-3.7K
Shares Outstanding
3.78M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Faith Zaslavsky | Chief Executive Officer | 394.1K | female |
| Sheri F. Gardzina | Chief Financial Officer & Corporate Secretary | 227.3K | female |
ESG Rating
ESG Score History MEDICAL - CARE FACILITIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BACK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
